SHIRE HUMAN GENETIC THERAPIES, INC. enters TRANSLATE BIO, INC. with 6.90M shares — 100% direct ownership
Full direct ownership at entry is the strongest form of insider alignment with shareholders.
Direct
Filed: 6/27/2018ACC: 0000950103-18-007853
10% Owner
Since Jul 2018
6.90M
Baseline shares
100% direct
6.90M
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned6.90M
Total
6.90M direct6.90M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 6.90M | Direct |
| Total | 6.90M | 6.90M direct |
Derivative Holdings0
No derivative holdings reported